著者
Shinji Sato Yoichi Kawanishi Masayuki Ide Noriko Sodeyama Hitoshi Takei
出版者
The Japanese Society of Clinical Neuropsychopharmacology
雑誌
Clinical Neuropsychopharmacology and Therapeutics (ISSN:18848826)
巻号頁・発行日
vol.10, pp.26-28, 2019-11-08 (Released:2019-11-08)
参考文献数
12

Autism spectrum disorder (ASD) includes disturbances in communication, imagination, and social interaction. In individuals with ASD, selective mutism is a common symptom of a communication disability. Selective serotonin reuptake inhibitors (SSRIs) have been recommended to treat selective mutism, especially after psychosocial interventions fail. However, the mechanism and efficacy of SSRIs in treating selective mutism remain unclear. Here we report the case of an adult male with ASD whose selective mutism was improved by aripiprazole but not SSRIs. To the best of our knowledge, this is the first such case report. We believe that our patient's case highlights the value of differentiating between psychopathology and psychopharmacology when examining ASD symptoms.

言及状況

外部データベース (DOI)

Twitter (3 users, 3 posts, 4 favorites)

場面緘黙の症状がある自閉症スペクトラムの成人男性(25)において、SSRIのフルボキサミンを服用しても症状に改善は認められなかったが、抗精神病薬のアリピプラゾールに切り替えてから徐々に他者に対して話し始めた事例。Mutism in… https://t.co/XMP5PjUnaJ

収集済み URL リスト